Literature DB >> 19167661

Detecting HIV associated neurocognitive disorders in adolescents: what is the best screening tool?

Maureen E Lyon1, Robert McCarter2, Lawrence J D'Angelo2.   

Abstract

PURPOSE: To examine the ability of the HIV-Dementia Scale (HDS) and Mini Mental State Exam (MMSE) to detect encephalopathy in adolescents living with human immunodeficiency virus (HIV) and/or acquired immunodeficiency syndrome (AIDS).
METHOD: The study was based on chart review (N = 71) from 1999 to 2006, extracting data from psychological testing, disease classification, and demographic variables. HDS and MMSE scores were independent. Diagnosis of encephalopathy used American Academy of Neurology Criteria. Receiver Operating Characteristic Curves were plotted.
RESULTS: Six patients had encephalopathy. The HDS identified five of these cases (83% sensitivity, 76% specificity). The MMSE identified three cases (50% sensitivity, 92% specificity).
CONCLUSION: Based on the study results, the HDS appears to be clinically useful.

Entities:  

Mesh:

Year:  2008        PMID: 19167661     DOI: 10.1016/j.jadohealth.2008.06.023

Source DB:  PubMed          Journal:  J Adolesc Health        ISSN: 1054-139X            Impact factor:   5.012


  10 in total

1.  Longitudinal Pediatric Palliative Care: Quality of Life & Spiritual Struggle (FACE): design and methods.

Authors:  Ronald H Dallas; Megan L Wilkins; Jichuan Wang; Ana Garcia; Maureen E Lyon
Journal:  Contemp Clin Trials       Date:  2012-06-01       Impact factor: 2.226

2.  Health literacy and adherence to antiretroviral therapy among HIV-infected youth.

Authors:  Ann-Margaret Navarra; Natalie Neu; Sima Toussi; John Nelson; Elaine L Larson
Journal:  J Assoc Nurses AIDS Care       Date:  2013-02-21       Impact factor: 1.354

3.  Engaging and Supporting Youth to Promote Adherence Success (EASYPAS): A Cognitive Behavioral Intervention for Youth Living With HIV.

Authors:  Ann-Margaret Dunn Navarra; Hannah Ford; Charles M Cleland; Eva Liang; Karla Rodriguez; Natalie Neu
Journal:  J Assoc Nurses AIDS Care       Date:  2019 May-Jun       Impact factor: 1.354

Review 4.  HIV-1 Tat-Mediated Calcium Dysregulation and Neuronal Dysfunction in Vulnerable Brain Regions.

Authors:  Xiu-Ti Hu
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

Review 5.  Screening for HIV-Associated Neurocognitive Disorders: Sensitivity and Specificity.

Authors:  Reuben N Robbins; Travis M Scott; Hetta Gouse; Thomas D Marcotte; Sean B Rourke
Journal:  Curr Top Behav Neurosci       Date:  2021

6.  Comparison of the Minimental State Examination Scale and the International HIV Dementia Scale in Assessing Cognitive Function in Nigerian HIV Patients on Antiretroviral Therapy.

Authors:  O Olajumoke Oshinaike; A Akinsegun Akinbami; O Oluwadamilola Ojo; I Frank Ojini; U Njideka Okubadejo; A Mustapha Danesi
Journal:  AIDS Res Treat       Date:  2012-09-25

Review 7.  A systematic review of the screening accuracy of the HIV Dementia Scale and International HIV Dementia Scale.

Authors:  Lewis John Haddow; Sian Floyd; Andrew Copas; Richard John Cary Gilson
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

8.  Is it safe? Talking to teens with HIV/AIDS about death and dying: a 3-month evaluation of Family Centered Advance Care (FACE) planning - anxiety, depression, quality of life.

Authors:  Maureen E Lyon; Patricia A Garvie; Linda Briggs; Jianping He; Robert Malow; Lawrence J D'Angelo; Robert McCarter
Journal:  HIV AIDS (Auckl)       Date:  2010-02-18

9.  Diagnostic accuracy of the International HIV Dementia Scale and HIV Dementia Scale: A meta-analysis.

Authors:  Xueying Hu; Yang Zhou; Jianxiong Long; Qiming Feng; Rensheng Wang; Li Su; Tingting Zhao; Bo Wei
Journal:  Exp Ther Med       Date:  2012-08-14       Impact factor: 2.447

Review 10.  Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature.

Authors:  Amy R Zipursky; David Gogolishvili; Sergio Rueda; Jason Brunetta; Adriana Carvalhal; Jennifer A McCombe; M John Gill; Anita Rachlis; Ron Rosenes; Gordon Arbess; Thomas Marcotte; Sean B Rourke
Journal:  AIDS       Date:  2013-09-24       Impact factor: 4.177

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.